Security key
82835W108
ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)
CUSIP: 82835W108
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 59,892,345
- Total 13F value
- $612,088,771
- Share change
- -5,533,508
- Put/Call ratio
- 9.5%
- SEC-reported price per share
- $10.22
- Number of holders
- 113
- Value change
- -$16,199,586
- Number of buys
- 63
- Number of sells
- 41
- Shares outstanding
- 99,255,583
Holder snapshot
7 facts
Show 1 more fact
Security identity
1 fact
Report period
Q1 2024
Institutions
113
Top holders
10
SPRY full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2024
Previous quarter: Q4 2023
ARS Pharmaceuticals, Inc. SEC filings
ARS Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 82835W108
Recent filing periods:
Ownership snapshot
Top reported holders of SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Largest current holder
DEERFIELD MANAGEMENT COMP...
13D/G signal
—
Evidence rows
15
Latest as of
31 Dec 2023
13F
Lead comparable stake: 11%
Showing 1-6 of 15 holder rows.
Quick read
DEERFIELD MANAGEMENT COMPANY, L.P. leads the comparable SEC ownership view at 11%.
Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
DEERFIELD MANAGEMENT COMPANY, L.P.
11%
RA CAPITAL MANAGEMENT, L.P.
9.5%
ORBIMED ADVISORS LLC
9.3%
FRANKLIN RESOURCES INC
4.1%
SR ONE CAPITAL MANAGEMENT, LP
4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
Company
|
11%
|
$60,707,040
11,077,927 shares
|
— | 31 Dec 2023 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
9.5%
|
$51,839,035
9,459,678 shares
|
— | 31 Dec 2023 |
| ORBIMED ADVISORS LLC |
13F
Company
|
9.3%
|
$50,640,061
9,240,887 shares
|
— | 31 Dec 2023 |
| FRANKLIN RESOURCES INC |
13F
Company
|
4.1%
|
$22,459,764
4,098,497 shares
|
— | 31 Dec 2023 |
| SR ONE CAPITAL MANAGEMENT, LP |
13F
Company
|
4%
|
$21,990,708
4,012,903 shares
|
— | 31 Dec 2023 |
| Charles Schwab Trust Co |
13F
Company
|
4%
|
$21,898,469
3,996,071 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
113
Shares
59,892,345
Rows available
113
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
99
Q1 2024 holders
113
Holder diff
14
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend